BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Somma T, Cinci L, Formicola G, Pini A, Thurmond R, Ennis M, Bani D, Masini E. A selective antagonist of histamine H4 receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1. Br J Pharmacol. 2013;170:200-213. [PMID: 23734568 DOI: 10.1111/bph.12264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohamed AF, El-yamany MF, El-batrawy FA, Abdel-aziz MT. JNJ7777120 Ameliorates Inflammatory and Oxidative Manifestations in a Murine Model of Contact Hypersensitivity via Modulation of TLR and Nrf2 Signaling. Inflammation 2018;41:378-89. [DOI: 10.1007/s10753-017-0693-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kollmeier AP, Barnathan ES, O'Brien C, Chen B, Xia YK, Zhou B, Loza MJ, Silkoff PE, Ge M, Thurmond RL. A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma. Ann Allergy Asthma Immunol 2018;121:568-74. [PMID: 30102965 DOI: 10.1016/j.anai.2018.08.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tatarkiewicz J, Rzodkiewicz P, Żochowska M, Staniszewska A, Bujalska-Zadrożny M. New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders. Arch Med Sci 2019;15:537-53. [PMID: 30899308 DOI: 10.5114/aoms.2017.68534] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kiss R, Keseru GM. Novel histamine H 4 receptor ligands and their potential therapeutic applications: an update. Expert Opinion on Therapeutic Patents 2014;24:1185-97. [DOI: 10.1517/13543776.2014.959494] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
5 Raina P, M. D, C.v. C, Agarwal A, Wagh N, Kaul-ghanekar R. Comparative analysis of anti-inflammatory activity of aqueous and methanolic extracts of Ocimum basilicum (basil) in RAW264.7, SW1353 and human primary chondrocytes in respect of the management of osteoarthritis. Journal of Herbal Medicine 2016;6:28-36. [DOI: 10.1016/j.hermed.2016.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Gangwar RS, Friedman S, Seaf M, Levi-schaffer F. Mast cells and eosinophils in allergy: Close friends or just neighbors. European Journal of Pharmacology 2016;778:77-83. [DOI: 10.1016/j.ejphar.2015.10.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
7 Liu Y, Yang Y, Ward R, An S, Guo X, Li W, Xu T. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways. Biochemical Journal 2015;470:155-67. [DOI: 10.1042/bj20150358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Thurmond RL, Venable J, Savall B, La D, Snook S, Dunford PJ, Edwards JP. Clinical Development of Histamine H4 Receptor Antagonists. Handb Exp Pharmacol 2017;241:301-20. [PMID: 28233185 DOI: 10.1007/164_2016_130] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
9 Nagarajan G, Thangam EB. Effect of H4R Antagonist N-(2-Aminoethyl)-5-Chloro-1H-Indole-2-Carboxamide (Compound A) in a Mouse Model of Allergic Asthma. Immunol Invest 2021;50:125-38. [PMID: 31985316 DOI: 10.1080/08820139.2020.1712415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL. Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 2014;349:176-84. [PMID: 24549371 DOI: 10.1124/jpet.113.211714] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
11 Merves J, Chandramouleeswaran PM, Benitez AJ, Muir AB, Lee AJ, Lim DM, Dods K, Mehta I, Ruchelli ED, Nakagawa H, Spergel JM, Wang ML. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis. PLoS One 2015;10:e0114831. [PMID: 25723478 DOI: 10.1371/journal.pone.0114831] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
12 Zhu LY, Ni ZH, Luo XM, Wang XB. Advance of antioxidants in asthma treatment. World J Respirol 2017; 7(1): 17-28 [DOI: 10.5320/wjr.v7.i1.17] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
13 Anoush M, Mohammad Khani MR. Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats. Adv Pharm Bull 2015;5:217-22. [PMID: 26236660 DOI: 10.15171/apb.2015.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev 2015;67:601-55. [PMID: 26084539 DOI: 10.1124/pr.114.010249] [Cited by in Crossref: 263] [Cited by in F6Publishing: 240] [Article Influence: 43.8] [Reference Citation Analysis]
15 Thurmond RL. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol 2015;6:65. [PMID: 25873897 DOI: 10.3389/fphar.2015.00065] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
16 Sulaiman I, Lim JC, Soo HL, Stanslas J. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation. Pulm Pharmacol Ther 2016;40:52-68. [PMID: 27453494 DOI: 10.1016/j.pupt.2016.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dorababu A. Update of Recently (2016–2020) Designed Azepine Analogs and Related Heterocyclic Compounds with Potent Pharmacological Activities. Polycyclic Aromatic Compounds. [DOI: 10.1080/10406638.2022.2041677] [Reference Citation Analysis]
18 Liu WL. Histamine H4 receptor antagonists for the treatment of inflammatory disorders. Drug Discovery Today 2014;19:1222-5. [DOI: 10.1016/j.drudis.2014.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
19 Kovacova-Hanuskova E, Gavliakova S, Buday T, Kosutova P, Mokra D, Urbanova-Fulmekova A, Mokry J, Plevkova J. The effect of selective antagonist of H4 receptor JNJ7777120 on nasal symptoms, cough, airway reactivity and inflammation in guinea pigs. Respir Physiol Neurobiol 2015;216:9-14. [PMID: 26003849 DOI: 10.1016/j.resp.2015.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Nagarajan G, Mariappanadar V, Tamizh M, Kaliappan I, Elden BT. Effect of H4R antagonist N -(2-aminoethyl)-5-chloro-1 H -indol-2-carboxamides and 5-chloro-2-(piperazin-1-ylmethyl)-1 H -benzimidazole on histamine and 4-methylhistamine-induced mast cell response. Journal of Receptors and Signal Transduction 2017;37:304-13. [DOI: 10.1080/10799893.2016.1247863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Lucarini L, Pini A, Gerace E, Pellicciari R, Masini E, Moroni F. Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling. J Cell Mol Med. 2014;18:468-479. [PMID: 24444146 DOI: 10.1111/jcmm.12197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
22 Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov 2021. [PMID: 34417579 DOI: 10.1038/s41573-021-00266-6] [Reference Citation Analysis]
23 Kollmeier AP, Greenspan A, Xu XL, Silkoff PE, Barnathan ES, Loza MJ, Jiang J, Zhou B, Chen B, Thurmond RL. Phase 2a, randomized, double-blind, placebo-controlled, multicentre, parallel-group study of an H4 R-antagonist (JNJ-39758979) in adults with uncontrolled asthma. Clin Exp Allergy 2018;48:957-69. [PMID: 29682796 DOI: 10.1111/cea.13154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]